Table 1.
Chronic lymphocytic leukemia patient characteristics.
| Median age (range) | 65 years (44–76) |
|---|---|
| Gender: | |
| Female | 12 (46%) |
| Male | 14 (54%) |
| Rai stage: | |
| 0 | 13 (50%) |
| 1 | 4 (15%) |
| 2 | 0 |
| 3 | 4 (15%) |
| 4 | 5 (20%) |
| Zap70: | |
| Zap70− | 12 (42%) |
| Zap70+ | 11 (46%) |
| Unknown | 3 (12%) |
| IgVH mutation status: | |
| IgHH− | 9 (34.5%) |
| IgVH+ | 15 (58%) |
| Unknown | 2 (7.5%) |
| Cytogenetics: | |
| 13q | 16 (61.5%) |
| t12 | 3 (11.5%) |
| TP53 | 5 (19%) |
| No mutations | 1 (4%) |
| Unknown | 1 (4%) |
| Secondary malignancies: | |
| Yes | 4 (15%) |
| No | 22 (85%) |
| Previous therapy | 1 (4%) |
| No previous therapy | 25 (96%) |